BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11574577)

  • 1. Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides.
    Werner G; Cuny C; Schmitz FJ; Witte W
    J Clin Microbiol; 2001 Oct; 39(10):3586-90. PubMed ID: 11574577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of quinupristin/dalfopristin resistance among livestock-associated Staphylococcus aureus ST9 clinical isolates.
    Yu F; Lu C; Liu Y; Sun H; Shang Y; Ding Y; Li D; Qin Z; Parsons C; Huang X; Li Y; Hu L; Wang L
    Int J Antimicrob Agents; 2014 Nov; 44(5):416-9. PubMed ID: 25218154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
    Aydeniz Ozansoy F; Cevahir N; Kaleli İ
    Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals.
    Haroche J; Morvan A; Davi M; Allignet J; Bimet F; El Solh N
    J Clin Microbiol; 2003 Feb; 41(2):586-91. PubMed ID: 12574251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
    Schmitz FJ; Verhoef J; Fluit AC
    J Antimicrob Chemother; 1999 Jun; 43(6):783-92. PubMed ID: 10404317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea.
    Kim HB; Lee B; Jang HC; Kim SH; Kang CI; Choi YJ; Park SW; Kim BS; Kim EC; Oh MD; Choe KW
    Microb Drug Resist; 2004; 10(3):248-54. PubMed ID: 15383170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Pupek J; Luczak M
    Med Dosw Mikrobiol; 2006; 58(3):199-205. PubMed ID: 17340994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides.
    Schmitz FJ; Witte W; Werner G; Petridou J; Fluit AC; Schwarz S
    J Antimicrob Chemother; 2001 Dec; 48(6):939-41. PubMed ID: 11733488
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
    Pavie J; Lefort A; Zarrouk V; Chau F; Garry L; Leclercq R; Fantin B
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3061-4. PubMed ID: 12183272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
    Vandendriessche S; Kadlec K; Schwarz S; Denis O
    J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
    Auckenthaler R; Courvalin P; Féger C; Roche G;
    Clin Microbiol Infect; 2000 Nov; 6(11):608-12. PubMed ID: 11168064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.